Fundraising Fox

Tessera

11 known investors

tesseratherapeutics.com ↗

Tessera Therapeutics develops Gene Writing, a genome engineering technology platform designed to make permanent alterations to the human genome for treating diseases. The company focuses on non-viral delivery methods to enable potentially curative genetic therapies.

BiotechDigital HealthMedical Devices

Investors · 11

Artis VenturesSan Francisco · $50K – $25M
Flagship PioneeringCambridge · $500K – $10M
March Capital PartnersSanta Monica
OMX VenturesLincolnshire
SoftBank Vision FundLondon
Solari CapitalNew York
Toba CapitalIrvine · $1M – $10M
Andreessen Horowitzreported · 2 sourcesMenlo Park · $500K – $50M
Foundation CapitalreportedSan Francisco · $250K – $15M
Myriad Venture Partnersreported
Osage University PartnersreportedBala Cynwyd

Founder mafia

2 people who came through Tessera went on to found or lead other companies.

Noubar AfeyanCo-Founder and Board MemberFounded ProFound Therapeutics +11Geoffrey von MaltzahnFounding CEO, Chairman of BoardFounded Sienna Biopharmaceuticals +4

In the news

Can AI Break the ERP Change-Order Cycle? Tessera Labs Just Raised $60M to Tryerp.today · Jun 2026Tessera Labs Raises $60 Million to Speed Enterprise Overhauls | Contract Pharmacontractpharma.com · May 2026Tessera Labs Raises $60M in Fundingfinsmes.com · May 2026Tessera Labs Raises $60M in Funding Led by Andreessen Horowitz to Transform ERP Modernizationbusinesswire.com · May 2026Sell or Invest in Tessera Therapeutics Stock Pre-IPOnasdaqprivatemarket.com · Oct 2024Tessera Therapeutics Raises Over $230M in Series B Financing - FinSMEsfinsmes.com · Jan 2021

Frequently asked questions

What does Tessera do?
Tessera Therapeutics develops Gene Writing, a genome engineering technology platform designed to make permanent alterations to the human genome for treating diseases. The company focuses on non-viral delivery methods to enable potentially curative genetic therapies.
Who are Tessera's investors?
Tessera's investors include Artis Ventures, Flagship Pioneering, March Capital Partners, OMX Ventures, SoftBank Vision Fund, Solari Capital, Toba Capital, Andreessen Horowitz and 3 more.